Market Runner: How Analysts Feel About Biostar Pharmaceuticals Inc After Today’s Huge Increase?

Market Runner: How Analysts Feel About Biostar Pharmaceuticals Inc After Today's Huge Increase?

The stock of Biostar Pharmaceuticals Inc (NASDAQ:BSPM) is a huge mover today! About 4.74 million shares traded hands or 159.02% up from the average. Biostar Pharmaceuticals Inc (NASDAQ:BSPM) has risen 75.94% since March 15, 2016 and is uptrending. It has outperformed by 70.46% the S&P500.
The move comes after 5 months positive chart setup for the $10.36M company. It was reported on Oct, 18 by Barchart.com. We have $7.71 PT which if reached, will make NASDAQ:BSPM worth $8.08 million more.

More important recent Biostar Pharmaceuticals Inc (NASDAQ:BSPM) news were published by: Investorplace.com which released: “Why Biostar Pharmaceuticals Inc (BSPM), Carbonite Inc (CARB) and Yum! Brands …” on October 11, 2016, also Prnewswire.com published article titled: “Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months …”, Benzinga.com published: “Crazy Stock Move Of The Day: Biostar Pharmaceuticals” on June 08, 2016. More interesting news about Biostar Pharmaceuticals Inc (NASDAQ:BSPM) was released by: Prnewswire.com and their article: “Biostar Pharmaceuticals Signs a Letter of Intent to Acquire Xianyang Yongsheng …” with publication date: September 22, 2016.

Biostar Pharmaceuticals, Inc. is a holding company. The company has a market cap of $10.36 million. The Company, through its subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar), and its variable interest entities (VIEs), Shaanxi Aoxing Pharmaceutical Co., Ltd. (Aoxing Pharmaceutical) and Shaanxi Weinan Huaren Pharmaceuticals Ltd. (Shaanxi Weinan), develops, makes and markets pharmaceutical products for various diseases and conditions in the People’s Republic of China (PRC or China). It currently has negative earnings. The Firm offers over-the-counter (OTC) products and prescription pharmaceuticals.

BSPM Company Profile

Biostar Pharmaceuticals, Inc. (Biostar), incorporated on March 27, 2007, is a holding company. The Company, through its subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar), and its variable interest entities (VIEs), Shaanxi Aoxing Pharmaceutical Co., Ltd. (Aoxing Pharmaceutical) and Shaanxi Weinan Huaren Pharmaceuticals Ltd. (Shaanxi Weinan), develops, makes and markets pharmaceutical products for various diseases and conditions in the People’s Republic of China (PRC or China). The Firm offers over-the-counter (OTC) products and prescription pharmaceuticals. The Company’s products are derived from medicinal herbs that are either grown at its own facility or purchased from its suppliers. The Company’s products are sold in approximately 30 provinces in the PRC through a network of over 60 distributors and through approximately 230 sales people.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment